Cardiotoxicity of imatinib mesylate: an extremely rare phenomenon or a major side effect?
AUTOR(ES)
Distler, Jörg H W
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1954675Documentos Relacionados
- Blepharospasm and periorbital edema after imatinib mesylate: improvement with botulinum toxin
- Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: Case report
- Adherence and/or discontinuation of imatinib mesylate in patients with chronic myeloid leukemia
- Preliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexed
- A rare side effect of escitalopram: bilateral peripheral edema